Clinical characterization of PLAG1- related Silver-Russell syndrome：A clinical report.

[1]  I. Netchine,et al.  IGF2: Development, Genetic and Epigenetic Abnormalities , 2022, Cells.

[2]  T. Eggermann,et al.  One test for all: whole exome sequencing significantly improves the diagnostic yield in growth retarded patients referred for molecular testing for Silver–Russell syndrome , 2021, Orphanet Journal of Rare Diseases.

[3]  Yerai Vado,et al.  Novel Variant in PLAG1 in a Familial Case with Silver–Russell Syndrome Suspicion , 2020, Genes.

[4]  K. Yamazawa,et al.  Contribution of gene mutations to Silver-Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients , 2020, Clinical Epigenetics.

[5]  T. Eggermann,et al.  HMGA2 variants in Silver-Russell syndrome: homozygous and heterozygous occurrence. , 2020, The Journal of clinical endocrinology and metabolism.

[6]  K. Yamazawa,et al.  Molecular and clinical analyses of two patients with UPD(16)mat detected by screening 94 patients with Silver-Russell syndrome phenotype of unknown aetiology , 2018, Journal of Medical Genetics.

[7]  Gareth Baynam,et al.  Silver Russel syndrome in an aboriginal patient from Australia , 2018, American journal of medical genetics. Part A.

[8]  T. Yuen,et al.  Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction , 2017, Genetics in Medicine.

[9]  P. Tounian,et al.  Effect of Cyproheptadine on Weight and Growth Velocity in Children With Silver-Russell Syndrome , 2017, Journal of pediatric gastroenterology and nutrition.

[10]  M. Maghnie,et al.  Diagnosis and management of Silver–Russell syndrome: first international consensus statement , 2017, Nature Reviews Endocrinology.

[11]  W. V. D. Van de Ven,et al.  Emerging role of PLAG1 as a regulator of growth and reproduction. , 2016, The Journal of endocrinology.

[12]  S. Chantot-Bastaraud,et al.  A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome , 2015, Journal of Medical Genetics.

[13]  M. Carella,et al.  A splicing mutation of the HMGA2 gene is associated with Silver–Russell syndrome phenotype , 2015, Journal of Human Genetics.

[14]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[15]  S. Fokstuen,et al.  Chromosomal rearrangements in patients with clinical features of Silver–Russell syndrome , 2014, American journal of medical genetics. Part A.

[16]  R. Mott,et al.  The Architecture of Parent-of-Origin Effects in Mice , 2014, Cell.

[17]  C. Larsson,et al.  Cell type and context-specific function of PLAG1 for IGF2 P3 promoter activity , 2012, International journal of oncology.

[18]  Y. Kamatani,et al.  A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. , 2010, Human Molecular Genetics.

[19]  C. Gicquel,et al.  Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome , 2005, Nature Genetics.

[20]  K. Kas,et al.  Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations , 1997, Nature Genetics.